In other words, the development of impaired insulin metabolic signaling and endothelial function can be promoted by excess circulating aldosterone, and sequentially contributes to hypertension and associated cardiovascular and renal structural and functional abnormalities. The gene discussed is INS; the disease is Hypertension.